Home > Boards > US Listed > Biotechs > GenVec, Inc (GNVC)

XON takeout of GNVC in all share deal

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
north40000 Member Profile
Member Level 
Followed By 172
Posts 15,164
Boards Moderated 0
Alias Born 01/19/06
160x600 placeholder
north40000 Member Level  Tuesday, 01/24/17 09:37:52 AM
Re: None
Post # of 3679 
XON takeout of GNVC in all share deal + CVRs.

http://finance.yahoo.com/news/intrexon-acquire-genvec-expand-industry-140000103.html

…GenVec stockholders will receive 0.297 of a share of Intrexon Common Stock in exchange for each share of GenVec common stock. This exchange ratio represents $7.00 per share of GenVec's common stock based on Intrexon's 5-day volume weighted average price as of January 23, 2017 [but only $6.56/sh based on XON’s latest price—see below].

GenVec stockholders will also receive a right to contingent consideration equal to 50% of any milestone or royalty payments received within 36 months after the closing of the transaction under GenVec's Research Collaboration and License Agreement with Novartis.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist